about
Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluidsDopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansTreadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorderNoradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trialCloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disordersPresence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participantsTreatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Methamphetamine craving induced in an online virtual reality environmentThe acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors.Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models.A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram.Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteersPreliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteersEffects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers.Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.Interferon-induced depression: strategies in treatment.Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteersThe impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouseMDMA use and neurocognition: a meta-analytic review.Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use DisorderRandomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteersSubjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudyUnrestricted access to methamphetamine or cocaine in the past is associated with increased current use.The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
P50
Q27312152-FFE43829-1B6C-4563-BEA2-DF0EA13B1AD6Q28265851-1A6D88E4-6DBF-4C1B-8AF2-F38A0A4E66BDQ28391787-1C169F1D-96F5-489D-88E4-755F318A7134Q28480500-3AD5D26F-E80B-4192-9526-D8B6F7724F75Q32062587-188F481E-DF58-4BF7-8EC0-79CB71F163E1Q33625390-D6FD79E8-60FD-4DFE-A9F2-F1A47F7ECEE2Q33838931-AF5408B0-62BE-4351-9910-8C12A7716BB3Q33993479-02C0DFD3-52E8-46A9-A209-2AC9C60BD3B0Q33993868-E401B37F-EAF4-403F-B786-211358EBF125Q33998159-542951FF-7631-4042-978C-4E036F725523Q34182993-1E494156-13C5-49A0-92DB-6C48A4FE306FQ34223546-504453EB-B9AB-496E-BAB4-6B675A664448Q34253787-EC48406D-BBA1-482B-A864-86C84DB01109Q34276018-BB357E21-70EB-429D-97E2-D1F3165FA672Q34564778-C6950C97-0566-4466-886C-AE091C076F3FQ35140394-60245487-510B-4D6B-B5AB-412D8DAEE2D1Q35489643-D22555EA-2B97-4C6D-8C1A-D98C3BAA1CBEQ35554545-C3E519E7-3331-4D12-8810-C2A5831FAE22Q35576598-D90E888F-55AC-4431-8D14-E473D33FCC28Q35580343-A7A0B2E8-DC8A-4C3A-A755-F38037E5C781Q35609711-9ACA4D2F-AEF3-4CA0-8C0D-ADBF9C73E322Q35609720-F60ABB60-8534-460E-94B7-AFFF49A7D06EQ35927314-A317458A-C235-4D7C-998B-9538EBE5A244Q35929403-08D78B67-B3B4-4B90-8B86-824EE9694FE0Q35974703-87DFB957-09F3-48E0-B94C-AA1D2395B0CBQ36036175-71FBCFD8-6153-4D1A-8D83-F73A0CAD8668Q36119083-99147B35-2771-4C2D-9D21-DCB633589588Q36133958-2D061C2E-893C-42DD-BBF7-DFA2EF937E84Q36139962-71A6435B-5E08-43BA-8FC5-27DFBE984C20Q36384712-E9CDF80A-FCFA-4CDE-B5B5-47D824436BDBQ36457583-125DF08E-7949-4847-BC64-70824531D069Q36513777-35210287-D9AE-435A-9C9B-681358EF1F00Q36643639-137AF777-DD01-41E2-8B38-F2F0540DA02BQ36650526-E3F2614E-7AEF-47C4-915A-F623D718EC80Q36749831-351D8BB3-5AE7-4BCD-8BAE-C825E72125C7Q36839403-A800BD99-CF6E-49AD-A7FF-D275B280CCE5Q36968973-A0DB3DC0-C4DA-4507-B4C2-93F090229BFDQ37137803-DADC1BBB-AC2F-41A5-BC5C-6533A07208C2Q37326864-6DE71953-BB3B-4DC0-8B71-A10BF2DB26A7Q37416909-A44B1BEC-8BA4-4285-AC1B-B8CC24819EE9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard De La Garza
@ast
Richard De La Garza
@en
Richard De La Garza
@es
Richard De La Garza
@nl
Richard De La Garza
@sl
type
label
Richard De La Garza
@ast
Richard De La Garza
@en
Richard De La Garza
@es
Richard De La Garza
@nl
Richard De La Garza
@sl
prefLabel
Richard De La Garza
@ast
Richard De La Garza
@en
Richard De La Garza
@es
Richard De La Garza
@nl
Richard De La Garza
@sl
P106
P1153
7003906211
P21
P31
P496
0000-0003-1943-4469